EP Europace

From WikiMD's WELLNESSPEDIA

EP Europace is a peer-reviewed medical journal that focuses on the field of cardiac electrophysiology and cardiac pacing. It is the official journal of the European Heart Rhythm Association (EHRA), a registered branch of the European Society of Cardiology (ESC).

History[edit]

EP Europace was first published in 1999 by Oxford University Press. The journal was established to provide a platform for the dissemination of scientific research and clinical practice in the field of cardiac electrophysiology and pacing.

Scope[edit]

The journal publishes original research articles, review articles, case reports, and editorials. The topics covered by EP Europace include, but are not limited to, arrhythmia, atrial fibrillation, ventricular tachycardia, cardiac resynchronization therapy, and sudden cardiac death.

Abstracting and Indexing[edit]

EP Europace is abstracted and indexed in several databases including PubMed, Scopus, and Web of Science. According to the Journal Citation Reports, the journal has a 2019 impact factor of 6.100.

Editorial Board[edit]

The editorial board of EP Europace is composed of leading experts in the field of cardiac electrophysiology and pacing from around the world. The current editor-in-chief is Professor Gerhard Hindricks from the University of Leipzig, Germany.

See Also[edit]

References[edit]

External Links[edit]

Stub icon

This medical article is a stub. You can help WikiMD by expanding the page.


Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.

Retrieved from "https://wikimd.org/index.php?title=EP_Europace&oldid=6528110"